IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL

被引:0
|
作者
Alexander, S. [1 ]
Auperin, A. [2 ]
Bomken, S. [3 ]
Csoka, M. [4 ]
Kazanowska, B. [5 ]
Chiang, A. [6 ]
Andres Moreno, M. [7 ]
Uyttebroeck, A. [8 ]
Burke, A. [9 ]
Zsiros, J. [10 ]
Pillon, M. [11 ]
Bollard, C. [12 ,13 ]
Barkauskas, D. [14 ]
Wheatley, K. [15 ]
Patte, C. [16 ,17 ]
Gross, T. [18 ]
Minard-Colin, V. [16 ,17 ]
机构
[1] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[2] Univ Paris Saclay, Unit Biostat & Epidemiol, Gustave Roussy, Villejuif, France
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Paediat Haematol & Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Semmelweis Univ, Dept Pediat Hematol & Oncol, Budapest, Hungary
[5] Wroclaw Med Univ, Dept Pediat Bone Marrow Transplantat Oncol & Hema, Wroclaw, Poland
[6] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Peoples R China
[7] Univ Valencia, Dept Pediat Hematol & Oncol, Valencia, Spain
[8] Univ Hosp Leuven, Dept Pediat Hematol & Oncol, Leuven, Belgium
[9] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Paediat Haematol Oncol & Palliat Care, Cambridge, England
[10] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[11] Univ Padua, Dept Pediat Hematol & Oncol, Padua, Italy
[12] George Washington Univ, Ctr Canc & Immunol Res, Washington, DC USA
[13] George Washington Univ, Washington, DC USA
[14] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA
[15] Royal Marsden NHS Fdn Trust, Dept Histopathol, London, England
[16] Univ Paris Saclay, Gustave Roussy, Dept Pediat, Villejuif, France
[17] Univ Paris Saclay, Gustave Roussy, Dept Adolescent Oncol, Villejuif, France
[18] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
011
引用
收藏
页码:S8 / S9
页数:2
相关论文
共 50 条
  • [1] Impact of Rituximab on Immune Status Following Therapy in Children with B-Cell Non-Hodgkin Lymphoma/Mature Acute Leukemia: A Report from Intergroup INTER-B-NHL RITUX 2010 Trial
    Alexander, S.
    Auperin, A.
    Pillon, M.
    Burke, A.
    Barkauskas, D. A.
    Wheatley, K.
    Delgado, R. F.
    Uyttebroeck, A.
    Bollard, C. M.
    Zsiros, J.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Patte, C.
    Gross, T. G.
    Minard-Colin, V.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S35 - S35
  • [2] Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
    Alexander, Sarah
    Auperin, Anne
    Bomken, Simon
    Csoka, Monika
    Kazanowska, Bernarda
    Chiang, Alan K.
    Andres, Mara
    Uyttebroeck, Anne
    Burke, G. A. Amos
    Pillon, Marta
    Bollard, Catherine M.
    Mussolin, Lara
    Verdu-Amoros, Jaime
    Neven, Benedicte
    Barkauskas, Donald A.
    Wheatley, Keith
    Patte, Catherine
    Gross, Thomas G.
    Minard-Colin, Veronique
    LANCET HAEMATOLOGY, 2023, 10 (06): : e445 - e457
  • [3] Results of the Randomized Intergroup Trial Inter-B-NHL RITUX 2010 for Children/Adolescents with High-Risk B-Cell Non Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL)
    Colin, V. Minard
    Auperin, A.
    Pillon, M.
    Burke, A.
    Anderson, J.
    Barkausk, D.
    Wheatley, K.
    Delgado, R.
    Alexander, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Goma, G.
    Tulard, A.
    Patte, C.
    Gross, T.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S31 - S31
  • [4] Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma
    Béranger Lueza
    Anne Aupérin
    Charlotte Rigaud
    Thomas G. Gross
    Marta Pillon
    Rafael F. Delgado
    Anne Uyttebroeck
    G. A. Amos Burke
    József Zsíros
    Monika Csóka
    Mathieu Simonin
    Catherine Patte
    Véronique Minard-Colin
    Julia Bonastre
    The European Journal of Health Economics, 2024, 25 : 307 - 317
  • [5] Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma
    Lueza, Beranger
    Auperin, Anne
    Rigaud, Charlotte
    Gross, Thomas G.
    Pillon, Marta
    Delgado, Rafael F.
    Uyttebroeck, Anne
    Burke, G. A. Amos
    Zsiros, Jozsef
    Csoka, Monika
    Simonin, Mathieu
    Patte, Catherine
    Minard-Colin, Veronique
    Bonastre, Julia
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (02): : 307 - 317
  • [6] Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial (vol 10, pg e445, 2023)
    Alexander, S.
    Auperin, A.
    Bomken, S.
    LANCET HAEMATOLOGY, 2023, 10 (06): : E399 - E399
  • [7] Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, Amos
    Anderson, James Robert
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine
    Zsiros, Jozsef
    Csoka, Monika
    Goma, Gisele
    Tulard, Anne
    Patte, Catherine
    Gross, Thomas G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, G. A. Amos
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael F.
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine M.
    Zsiros, Jozsef
    Csoka, Monika
    Kazanowska, Bernarda
    Chiang, Alan K.
    Miles, Rodney R.
    Wotherspoon, Andrew
    Adamson, Peter C.
    Vassal, Gilles
    Patte, Catherine
    Gross, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2207 - 2219
  • [9] INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY
    Minard-Colin, V.
    Auperin, A.
    Burke, A.
    Alexander, S.
    Moreno, M.
    Buffardi, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Verschuur, A.
    Miles, R.
    Wotherspoon, A.
    Barkauskas, D.
    Wheatley, K.
    Vassal, G.
    Adamson, P.
    Gross, T.
    Patte, C.
    Pillon, M.
    LEUKEMIA RESEARCH, 2022, 121 : S43 - S43
  • [10] Where is the place for rituximab in the treatment of B-cell non-Hodgkin lymphoma (B-NHL) of children and adolescents?
    Patte, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 110 - 110